Highlights and Quick Summary
- Equity Repurchase (Common, Net) for the quarter ending March 31, 2023 was $73.5 Million (a Infinity% increase compared to previous quarter)
- Year-over-year quarterly Equity Repurchase (Common, Net) increased by Infinity%
- Annual Equity Repurchase (Common, Net) for 2022 was $1 Thousand (a -100.0% decrease from previous year)
- Annual Equity Repurchase (Common, Net) for 2021 was $122 Million (a 246.42% increase from previous year)
- Annual Equity Repurchase (Common, Net) for 2020 was $35.1 Million (a 407.18% increase from previous year)
- Twelve month Equity Repurchase (Common, Net) ending March 31, 2023 was $73.5 Million (a 7350000.0% increase compared to previous quarter)
- Twelve month trailing Equity Repurchase (Common, Net) increased by 20488.52% year-over-year
Trailing Equity Repurchase (Common, Net) for the last four month:
| 31 Mar '23 | 31 Dec '22 | 30 Sep '22 | 30 Jun '22 |
|---|---|---|---|
| $73.5 Million | $1 Thousand | $6 Thousand | $357 Thousand |
Visit stockrow.com/PGEN
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Equity Repurchase (Common, Net) of Precigen, Inc.
Most recent Equity Repurchase (Common, Net)of PGEN including historical data for past 10 years.Interactive Chart of Equity Repurchase (Common, Net) of Precigen, Inc.
Precigen, Inc. Equity Repurchase (Common, Net) for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $73.5 | – | – | – | – |
| 2022 | $0.0 | $0.0 | $0.0 | $0.0 | $0.0 |
| 2021 | $0.01 | $0.35 | $0.14 | $121.16 | $121.65 |
| 2020 | $0.05 | $0.0 | $0.07 | $35.0 | $35.12 |
| 2019 | $0.0 | $0.01 | $0.0 | $6.92 | $6.92 |
| 2018 | $1.26 | $0.14 | $0.61 | $88.31 | $90.33 |
| 2017 | $13.8 | $0.19 | $0.5 | $0.18 | $14.67 |
| 2016 | $0.99 | $0.51 | $7.89 | $9.78 | $19.17 |
| 2015 | $2.25 | $220.02 | $7.82 | $112.61 | $342.7 |
| 2014 | $0.22 | $0.3 | $0.65 | $25.33 | $26.49 |
| 2013 | $0.36 | $168.85 | $0.0 | $0.01 | $169.22 |
| 2012 | $0.07 | $0.18 | – | – | $0.47 |
Business Profile of Precigen, Inc.
Sector: Healthcare
Industry: Biotechnology